Compare Cassava Sciences Inc (FLNA) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Tencent Music Entertainment Group - ADR — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Tencent Music Entertainment Group - ADR trades at $8.38 (market cap $12.83B). The key difference: Tencent Music Entertainment Group - ADR is far larger — about 325.6× Cassava Sciences Inc's market cap, and Tencent Music Entertainment Group - ADR pays a 3.02% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Tencent Music Entertainment Group - ADR for 67 Days on average.
| FLNA | TME | |
|---|---|---|
Market Cap | $39.40M | $12.83B |
Volume | 759,018 | 3,618,478 |
Sector | Health | Media |
52-Week High | $4.64 | $23.71 |
52-Week Low | $0.68 | $7.74 |
Typical Hold Time | 37 Days | 67 Days |
Enterprise Value | -$43.28M | $10.77B |
Dividend Yield | — | 3.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8136, down 0.26% with a bearish technical signal. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates for three consecutive quarters. Recent positive FDA news regarding the clinical hold lift on simufilam for epilepsy research provides a potential catalyst. Cash flow remains negative with net cash flow of -$33.07M in 2025.
The outlook is mixed with strong analyst support (66.7% buy ratings) against fundamental challenges. Investment opportunity lies in clinical trial success, while risks include sustained cash burn and execution hurdles. The stock's low EV/EBITDA of 1.03 and P/B of 0.62 suggest undervaluation if pipeline milestones are met.
Tencent Music Entertainment (TME) trades at $7.96, down 0.38% with bearish technical signals. The company shows strong fundamentals with $32.9B revenue, 33.6% net margin, and attractive valuation ratios (P/E 9.33, P/S 2.46). Recent Q2 2026 earnings beat expectations, but sentiment is mixed amid competitive pressures and slowing growth in some segments.
TME presents a value opportunity with discounted valuation and robust profitability, though facing headwinds from intense competition and user churn. The $12.50 consensus price target suggests 57% upside potential, but investors should monitor execution of the subscription pivot and competitive threats from short-form video platforms.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
